Edition:
United States

Alliqua BioMedical Inc (ALQA.OQ)

ALQA.OQ on NASDAQ Stock Exchange Capital Market

3.28USD
23 Oct 2017
Change (% chg)

$0.01 (+0.31%)
Prev Close
$3.27
Open
$3.26
Day's High
$3.32
Day's Low
$3.17
Volume
9,655
Avg. Vol
12,314
52-wk High
$8.47
52-wk Low
$2.30

Latest Key Developments (Source: Significant Developments)

Alliqua Biomedical announces 1-for-10 reverse stock split
Thursday, 5 Oct 2017 04:01pm EDT 

Oct 5 (Reuters) - Alliqua Biomedical Inc :Alliqua Biomedical Inc announces 1-for-10 reverse stock split.Company's common stock will begin trading on split-adjusted basis on Friday, October 6, 2017.  Full Article

Alliqua Biomedical sells TheraBond 3D Antimicrobial Barrier Systems product line
Tuesday, 5 Sep 2017 07:30am EDT 

Sept 5 (Reuters) - Alliqua Biomedical Inc :Alliqua Biomedical Inc announces the sale of TheraBond 3D Antimicrobial Barrier Systems product line; Alliqua updates fiscal year outlook.Sees FY 2017 revenue up about 13 to 19 percent.Sees FY 2017 revenue $18.4 million to $19.3 million.Alliqua Biomedical Inc - for fiscal year 2017 company still expects cash burn from operations to be approximately $12.0 million.Alliqua Biomedical says Alliqua sold all assets associated with its TheraBond 3D Antimicrobial Barrier Systems product line to Argentum Medical, LLC.Alliqua Biomedical Inc - Alliqua will use proceeds from sale for working capital purposes and to reduce its outstanding debt balance.Alliqua Biomedical Inc - as a result of the transaction, company's lender has agreed to defer all principal payments until January 31, 2018.Alliqua Biomedical Inc - aggregate purchase price for TheraBond product line was approximately $3.8 million.Alliqua Biomedical - net of payments to Alliqua's senior secured lender of $1.65 million, Alliqua received proceeds of approximately $1.65 million at closing.  Full Article

Alliqua Biomedical posts Q2 adj. $0.09/shr from continuing operations
Thursday, 10 Aug 2017 07:00am EDT 

Aug 10 (Reuters) - Alliqua Biomedical Inc :Alliqua Biomedical Inc reports second quarter of fiscal year 2017 financial results.Q2 non-GAAP loss per share $0.09 from continuing operations.Q2 GAAP loss per share $0.09.Q2 revenue rose 24 percent to $5.5 million.Sees FY 2017 revenue up about 12 to 17 percent.Sees FY 2017 revenue $20.4 million to $21.3 million.  Full Article

Alliqua announces partnership with Partners Capital Group
Monday, 19 Jun 2017 07:30am EDT 

June 19 (Reuters) - Alliqua Biomedical Inc ::Alliqua Biomedical Inc announces partnership with Partners Capital Group to provide Ultramist® customers with new equipment financing programs.Alliqua Biomedical - entered into partnership with Partners Capital Group to provide potential Ultramist customers with new equipment financing programs.  Full Article

Alliqua Biomedical reports Q1 loss per share of $0.23
Tuesday, 9 May 2017 07:00am EDT 

May 9 (Reuters) - Alliqua Biomedical Inc :Alliqua biomedical, inc. Reports first quarter of fiscal year 2017 financial results.Q1 non-GAAP loss per share $0.17 from continuing operations.Q1 GAAP loss per share $0.23.Q1 revenue $4.6 million versus I/B/E/S view $4.4 million.Q1 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue up about 12 to 17 percent.Sees FY 2017 revenue $20.4 million to $21.3 million.FY2017 revenue view $20.3 million -- Thomson Reuters I/B/E/S.For fiscal year 2017, company expects cash burn from operations to approximate $12.0 million.  Full Article

Alliqua Biomedical says Company, unit and perceptive entered into amendment No.2 to forbearance and amendment agreement
Monday, 1 May 2017 09:31am EDT 

May 1 (Reuters) - Alliqua Biomedical Inc :Alliqua biomedical - on april 27, 2017, company, unit and perceptive entered into amendment no.2 to forbearance and amendment agreement - sec filing.Alliqua biomedical inc - pursuant to amedment perceptive agreed to extend forbearance period until earlier of june 30, 2017.  Full Article

Alliqua Biomedical says co, Perceptive enters amendment to reduce exercise price
Wednesday, 12 Apr 2017 01:34pm EDT 

Alliqua Biomedical Inc :On April 6, co, Perceptive entered amendment, restatement of third amended warrant to reduce exercise price from $0.50 to $0.47.  Full Article

Alliqua Biomedical sees Q1 revenue about $4.6 million
Thursday, 6 Apr 2017 07:30am EDT 

Alliqua Biomedical Inc : Alliqua Biomedical, Inc announces preliminary first quarter fiscal 2017 revenue and updates fiscal year 2017 outlook; earnings conference call scheduled for may 9, 2017 . Sees Q1 revenue about $4.6 million . Sees FY 2017 revenue up about 12 to 17 percent . Sees FY 2017 revenue $20.4 million to $21.3 million . Alliqua Biomedical - estimates that sales of products were $4.4 million and that contract manufacturing sales were approximately $225,000 for q1 of 2017 . Alliqua Biomedical - fy 2017 total revenue guidance now assumes contract manufacturing sales of about $1.4 million, versus $2.2 million in fy ended dec 31, 2016 .Fy 2017 total revenue guidance continues to assume product sales of $19.0 million to $19.9 million.  Full Article

Alliqua Biomedical announces pricing of public offering of common stock
Wednesday, 29 Mar 2017 07:30am EDT 

Alliqua Biomedical Inc : Alliqua Biomedical Inc announces pricing of public offering of common stock .Says public offering of 9.38 million common shares priced at $0.40 per share.  Full Article

Alliqua Biomedical plans to sell shares in public offering
Tuesday, 28 Mar 2017 04:25pm EDT 

Alliqua Biomedical Inc : Alliqua Biomedical Inc announces proposed public offering of common stock .Alliqua Biomedical - to use proceeds to pay co's monthly payment obligations under its credit agreement with perceptive credit opportunities fund, L.P..  Full Article